Logo
Chat With Us

Tolterodine Tartrate ER Tablets

  1. Home
  2. Tolterodine Tartrate ER Tablets

Tolterodine Tartrate ER Tablets

Categories : Nephrology & Urology

Product Packaging : 10 / 30 tablets

Product Composition : 2 mg

Tolterodine Tartrate ER (Extended Release) Tablets are an antimuscarinic formulation indicated for the management of overactive bladder (OAB) with symptoms such as urinary urgency, increased frequency, and urge incontinence. The extended-release technology ensures sustained drug delivery over 24 hours, improving bladder control and reducing sudden urinary urges.

Genliva Wellness LLP offers Tolterodine Tartrate ER Tablets produced through advanced GMP-certified manufacturing systems, ensuring consistent quality, controlled release performance, and regulatory compliance. The product is designed for chronic urology therapy markets, including branded generics, institutional supply, and international distribution.

This formulation is widely used in urology practice and long-term bladder control therapy, making it suitable for both outpatient and specialty care segments.

Send Message

Tolterodine Tartrate ER (Extended Release) Tablets are an antimuscarinic formulation indicated for the management of overactive bladder (OAB) with symptoms such as urinary urgency, increased frequency, and urge incontinence. The extended-release technology ensures sustained drug delivery over 24 hours, improving bladder control and reducing sudden urinary urges.

Genliva Wellness LLP offers Tolterodine Tartrate ER Tablets produced through advanced GMP-certified manufacturing systems, ensuring consistent quality, controlled release performance, and regulatory compliance. The product is designed for chronic urology therapy markets, including branded generics, institutional supply, and international distribution.

This formulation is widely used in urology practice and long-term bladder control therapy, making it suitable for both outpatient and specialty care segments.

  • Premium-quality Tolterodine Tartrate ER Tablets manufactured in India
  • Effective extended-release formulation for 24-hour bladder control
  • Proven antimuscarinic action to reduce urinary urgency and frequency
  • Suitable for long-term overactive bladder (OAB) management
  • Available in strengths such as Tolterodine Tartrate ER 2 mg / 4 mg tablets
  • Designed for consistent release profile and improved tolerability
  • Manufactured under validated processes ensuring batch-to-batch uniformity
  • Flexible supply options for branded generics, institutional demand, and distributors
  • Supported with regulatory documentation and quality certifications

Tolterodine Tartrate ER Tablets are commonly prescribed for:

  • Treatment of overactive bladder (OAB)
  • Management of urinary urgency and frequency
  • Control of urge urinary incontinence
  • Improvement of bladder storage function
  • Reduction of involuntary bladder contractions
  • Support in chronic bladder dysfunction management
  • Extended-release tablet ensures once-daily dosing convenience
  • Provides controlled and sustained drug release over 24 hours
  • Enhances patient compliance in long-term therapy
  • Minimizes peak-related side effects compared to immediate-release forms
  • Stable formulation supports global distribution and varied climate conditions
  • Suitable for blister and bottle packaging formats
  • Ideal for large-scale procurement and chronic therapy programs
whatsapp-app